Skip to content
Clinical Trials – home

Infertility female Life with Disease

15 / 22 trials open to patients7 countries

In short

Infertility in women is a medical condition that can affect both physical health and emotional wellbeing. Understanding what to expect, how the condition may progress, and what support is available can help women and their families navigate this challenging journey with greater confidence and hope.

Key points

  • At least 10% of women deal with some form of infertility, making it a common medical condition that affects millions worldwide.
  • Age is the single most important factor affecting female fertility, with chances of pregnancy declining significantly after age 35.
  • Many couples diagnosed with infertility do eventually have children, either with medical assistance or sometimes without treatment.
  • Ovulation problems, often caused by PCOS, are the leading cause of female infertility and frequently respond well to medication.
  • Untreated sexually transmitted infections can lead to pelvic inflammatory disease, which damages fallopian tubes and causes infertility.
  • The emotional impact of infertility can be as significant as the physical challenges, requiring proper mental health support.
  • Lifestyle factors like maintaining healthy weight, avoiding smoking, and managing stress can improve fertility outcomes.
  • Clinical trials may offer access to cutting-edge fertility treatments that aren't yet widely available to the public.

Prognosis and Outlook

The outlook for women experiencing infertility can vary significantly depending on the underlying cause, age, and overall health. It's important to approach this topic with sensitivity, as infertility affects people differently, and each person's journey is unique.

Many women who receive an infertility diagnosis do go on to have children, sometimes with medical assistance and sometimes without any treatment at all. Studies show that approximately 85% of women under 35 will conceive within 12 months of trying, which means that a significant portion of couples who struggle initially may still achieve pregnancy within the first year. For those who require medical intervention, various treatment options can improve the chances of conception.

Age plays a critical role in determining the likelihood of successful pregnancy. For women in their mid-30s and beyond, fertility naturally declines as the quality and quantity of eggs decrease over time. A woman aged 40 has only about a 5% chance of pregnancy per menstrual cycle, compared to younger women who have higher monthly chances. This doesn't mean pregnancy is impossible, but it does mean that timing becomes increasingly important, and medical help may be needed sooner rather than later.

The specific cause of infertility also influences prognosis. Women with ovulatory disorders, such as polycystic ovary syndrome (PCOS)—a condition where the ovaries may not release eggs regularly—often respond well to medications that stimulate ovulation. About 70% of women with anovulation (not releasing eggs) have PCOS. On the other hand, conditions like blocked fallopian tubes or severe endometriosis may require surgical intervention or assisted reproductive technologies like in vitro fertilization (IVF), where an egg is fertilized outside the body in a laboratory.

It's worth noting that in about 15% of infertile couples, no identifiable cause can be found. This is called unexplained infertility, and while it can be frustrating not to have clear answers, many of these couples still achieve pregnancy with time or treatment.

Natural Progression Without Treatment

When infertility is left untreated, the natural progression depends heavily on the underlying cause. For some women, the condition may remain stable, while for others, certain factors may worsen over time, further reducing the chances of natural conception.

If a woman has irregular or absent menstrual periods due to hormonal imbalances, this pattern is likely to continue without intervention. Conditions affecting ovulation, such as thyroid disorders or high levels of prolactin (a hormone produced by the pituitary gland), will persist and continue to prevent regular egg release unless addressed medically. Over time, without treatment, the window of opportunity for natural conception narrows, especially as a woman ages.

For women with structural problems, such as endometriosis—a condition where tissue similar to the lining of the womb grows outside the uterus—the disease may progress. Endometriosis can cause scarring of the fallopian tubes and ovaries, making it increasingly difficult for an egg to travel and be fertilized. Similarly, untreated sexually transmitted infections can lead to pelvic inflammatory disease (PID), which damages and scars the fallopian tubes, creating blockages that prevent pregnancy.

Women with conditions like uterine fibroids or polyps may find that these growths increase in size or number over time. While not all fibroids or polyps affect fertility, larger ones or those in certain locations can interfere with the implantation of a fertilized egg or block the fallopian tubes.

Age-related decline in fertility is perhaps the most inevitable form of natural progression. Women are born with a finite number of eggs, and this supply diminishes throughout life. As eggs age, they become less viable and more likely to have chromosomal abnormalities, which increases the risk of miscarriage and genetic issues in a baby. This process accelerates after age 35, meaning that delaying treatment can significantly reduce the likelihood of successful conception.

In cases of unexplained infertility, it's difficult to predict what will happen without treatment. Some couples may eventually conceive naturally after months or years, while others may not. The lack of a clear diagnosis means that the body's reproductive system may simply require more time, or there may be subtle issues that current testing cannot detect.

Possible Complications

Infertility itself can lead to various complications, both physical and emotional. Some of these complications arise from the underlying conditions causing infertility, while others may result from the stress and treatments associated with trying to conceive.

One significant complication is the increased risk of ectopic pregnancy, where a fertilized egg implants outside the uterus, often in a fallopian tube. This is more common in women with damaged or scarred fallopian tubes due to conditions like pelvic inflammatory disease or endometriosis. Ectopic pregnancies are serious and can be life-threatening if not treated promptly, as they can cause internal bleeding.

Women with infertility may also experience recurrent pregnancy loss, defined as having two or more miscarriages. This can be caused by chromosomal abnormalities in the eggs, hormonal imbalances, uterine abnormalities, or other factors. Each loss can be physically draining and emotionally devastating.

Certain treatments for infertility carry their own risks. Medications used to stimulate ovulation, called gonadotropins, can lead to multiple pregnancies—such as twins or triplets—in up to 36% of cycles, depending on the specific therapy used. Multiple pregnancies carry higher risks for both mother and babies, including premature birth, low birth weight, and complications during delivery. Another potential complication from ovulation-stimulating drugs is ovarian hyperstimulation syndrome, which occurs in 1% to 5% of treatment cycles. This condition involves the ovaries becoming swollen and painful, and in severe cases can cause fluid buildup in the abdomen, electrolyte imbalances, and blood clotting issues.

Untreated conditions that cause infertility can also lead to other health problems. For example, polycystic ovary syndrome is associated with an increased risk of developing type 2 diabetes, high blood pressure, and heart disease later in life. Endometriosis, if left untreated, can cause chronic pelvic pain and may require more extensive surgical intervention over time.

The emotional and psychological complications of infertility are profound. Many women experience depression, anxiety, and feelings of isolation. The stress of repeated treatment cycles, financial burden, and social pressures can strain relationships and affect overall quality of life. These psychological effects are recognized as a significant part of the infertility experience and deserve attention and care.

Impact on Daily Life

Infertility affects far more than just the ability to conceive. It touches nearly every aspect of a woman's daily life, from her physical health to her emotional wellbeing, social relationships, work performance, and sense of identity.

Physically, the process of trying to conceive and undergoing fertility treatments can be demanding. Women may need to attend frequent medical appointments for blood tests, ultrasounds, and procedures. Fertility medications can cause side effects such as mood swings, bloating, headaches, and hot flashes. The physical discomfort and time commitment required for treatments can make it difficult to maintain a normal routine.

Emotionally, infertility can feel like a rollercoaster. Each month brings a cycle of hope and disappointment. The anticipation during the two-week wait—the period between ovulation and when a pregnancy test can be taken—can be especially stressful. When a period arrives or a test is negative, it can feel like a personal loss, even if a pregnancy was never achieved. These repeated disappointments can lead to chronic stress, anxiety, and depression.

Social situations can become challenging. Events like baby showers, family gatherings, or casual conversations about children can trigger painful emotions. Some women feel judged or pressured by well-meaning friends and family who ask about plans for children or offer unsolicited advice. The feeling of being different or "broken" compared to peers who conceive easily can lead to social withdrawal and isolation.

Work life may also be affected. The need for frequent medical appointments, the emotional toll of treatment cycles, and the physical side effects of medications can make it difficult to concentrate and perform at work. Some women may struggle with deciding whether to disclose their situation to employers or colleagues, fearing judgment or discrimination.

Intimate relationships often experience strain. The pressure to have timed intercourse during fertile windows can make intimacy feel like a chore rather than a spontaneous expression of love. Partners may grieve differently or struggle to communicate about their feelings, leading to misunderstandings and tension. It's important for couples to make time for connection that isn't focused solely on conception.

Hobbies and leisure activities may lose their appeal when a woman is consumed by thoughts of infertility and treatment. However, maintaining activities that bring joy and relaxation is crucial for mental health. Exercise, creative pursuits, and spending time in nature can provide much-needed respite from the stress of trying to conceive.

Financial concerns add another layer of stress. Fertility treatments can be expensive, and not all insurance plans cover these costs. The financial burden can limit treatment options and add to the overall anxiety about the situation.

Despite these challenges, many women find ways to cope and maintain resilience. Building a support network, whether through friends, family, support groups, or professional counseling, can make a significant difference. Allowing yourself to acknowledge and express your feelings, rather than suppressing them, is an important part of emotional healing.

Support for Family and Finding Clinical Trials

Family members and partners play a crucial role in supporting a woman dealing with infertility. Understanding what their loved one is going through and knowing how to help can make the journey less isolating and more manageable.

One of the most important things family members can do is listen without judgment. Sometimes a woman just needs to express her feelings without receiving advice or being told to "just relax" or "stop trying so hard." These well-intentioned comments can feel dismissive and hurtful. Instead, simply being present and acknowledging the pain can be incredibly supportive.

Partners should recognize that infertility affects both people in a relationship, even if the medical issue lies with one person. Attending medical appointments together, participating in treatment decisions, and sharing emotional burdens can strengthen the relationship. It's also important for partners to communicate openly about their own feelings and needs.

Family members can help by being sensitive about questions related to having children. Constant inquiries about when a couple will have a baby can add pressure and pain. Respecting privacy and letting the woman share information on her own terms is important. If she does choose to confide in family members, they should honor that trust by maintaining confidentiality.

When it comes to clinical trials, family members can assist in several ways. Clinical trials are research studies that test new treatments or approaches to fertility care. They can offer access to cutting-edge therapies that may not yet be widely available, sometimes at reduced cost or even free of charge.

Family members can help by researching available clinical trials for infertility. Many fertility centers and research institutions conduct studies on new medications, procedures, or diagnostic tools. Websites maintained by government health agencies and medical institutions often list current clinical trials and their eligibility requirements. Helping to gather this information and organize options can relieve some of the burden on the woman undergoing treatment.

Before enrolling in a clinical trial, it's important to understand what participation involves. Family members can help by accompanying the woman to informational meetings, asking questions about the study protocol, potential risks and benefits, time commitments, and costs. Understanding whether the trial is testing a completely new treatment or comparing existing treatments can help in making an informed decision.

Preparing for trial participation may involve additional tests, more frequent monitoring, and strict adherence to study protocols. Family members can provide practical support by helping with transportation to appointments, keeping track of medication schedules, and providing emotional encouragement throughout the process.

It's also important to recognize that clinical trials may not be the right choice for everyone. They carry both potential benefits—such as access to new treatments—and potential risks, including unknown side effects or the possibility of receiving a placebo instead of an active treatment. Discussing these factors with healthcare providers and as a family can help in making the best decision.

Throughout the infertility journey, whether pursuing standard treatment or clinical trials, family support remains vital. Simple gestures like preparing a meal, offering to take care of other responsibilities, or just providing a listening ear can make a significant difference. Remember that infertility is a medical condition, not a personal failing, and approaching it with compassion and understanding benefits everyone involved.

Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Clomiphene citrate – Encourages the monthly release of an egg (ovulation) in women who do not ovulate regularly or cannot ovulate at all
  • Letrozole (aromatase inhibitor) – Used to induce ovulation or for ovarian stimulation during in vitro fertilization cycles
  • Tamoxifen – An alternative to clomiphene that may be offered if you have ovulation problems
  • Metformin – Particularly beneficial for women who have polycystic ovary syndrome (PCOS)
  • Gonadotrophins – Hormones that can help stimulate ovulation in women, and may also improve fertility in men
  • Gonadotrophin-releasing hormone agonists – Prescribed to encourage ovulation in women
  • Dopamine agonists – Used to encourage ovulation in women

Did you know?

  1. Approximately one in six people of reproductive age worldwide experience infertility in their lifetime, making it a global health concern affecting millions.
  2. In about one-third of infertile couples, both male and female factors contribute to infertility, highlighting that it's often not just one partner's issue.
  3. A woman's monthly chance of conceiving drops to just 5% per menstrual cycle by age 40, compared to 25% for younger fertile couples, showing how dramatically age affects fertility.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Infertility female

Recruiting trials first

See all 22 trials →
Quick filters

22 clinical trials in this condition

Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Follitropin Delta
  • Sponsor:Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Progesterone
  • Sponsor:Region Midtjylland
Countries:SpainSpain
  • Participants:18–64 years · Healthy volunteers
  • Substances:Corifollitropin Alfa
  • Sponsor:Ivi Valencia S.L.
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Metformin Hydrochloride
  • Sponsor:Agencja Badań Medycznych
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Cetrorelix
  • Sponsor:Santiago Dexeus Font Fundacio Privada
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Ganirelix
  • Sponsor:Ginefiv S.L.
See all 22 trials →filters applied: condition = Infertility female

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).